QQ客服 官方微博 反馈留言

	Wedelolactone exhibits anti-fibrotic effects on human hepatic stellate cell line LX-2
	Xia, Yanzhe[1]; Chen, Jie[1]; Cao, Yuan[1]; Xu, Chenshu[1]; Li, Ruiming[1]; Pan, Yuhua[1]; Chen, Xiao[1]
刊名	EUROPEAN JOURNAL OF PHARMACOLOGY
	2013
卷号	714页码:105-111
关键词	Wedelolactone Liver fibrosis Hepatic stellate cell NF-kappa B Apoptosis
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2221617
专题	华南理工大学
作者单位	Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pharm, Guangzhou 510080, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Xia, Yanzhe[1],Chen, Jie[1],Cao, Yuan[1],et al. Wedelolactone exhibits anti-fibrotic effects on human hepatic stellate cell line LX-2[J]. EUROPEAN JOURNAL OF PHARMACOLOGY,2013,714:105-111.
APA	Xia, Yanzhe[1].,Chen, Jie[1].,Cao, Yuan[1].,Xu, Chenshu[1].,Li, Ruiming[1].,...&Chen, Xiao[1].(2013).Wedelolactone exhibits anti-fibrotic effects on human hepatic stellate cell line LX-2.EUROPEAN JOURNAL OF PHARMACOLOGY,714,105-111.
MLA	Xia, Yanzhe[1],et al."Wedelolactone exhibits anti-fibrotic effects on human hepatic stellate cell line LX-2".EUROPEAN JOURNAL OF PHARMACOLOGY 714(2013):105-111.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。